The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Paul N. Span

Department of Chemical Endocrinology

Radboud University Nijmegen Medical Centre




Name/email consistency: high



  • Department of Chemical Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. 2003 - 2009


  1. Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: an EU-FP6 supported study of members of the EORTC - PathoBiology Group. Span, P.N., Sieuwerts, A.M., Heuvel, J.J., Spyratos, F., Duffy, M.J., Eppenberger-Castori, S., Vacher, S., O'Brien, K., McKiernan, E., Pierce, A., Vuaroqueaux, V., Foekens, J.A., Sweep, F.C., Martens, J.W. Eur. J. Cancer (2009) [Pubmed]
  2. Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues. Span, P.N., Witjes, J.A., Grebenchtchikov, N., Geurts-Moespot, A., Moonen, P.M., Aalders, T.W., Vriesema, J.L., Kiemeney, L.A., Schalken, J.A., Sweep, F.C. BJU Int. (2008) [Pubmed]
  3. High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Span, P.N., Tjan-Heijnen, V.C., Manders, P., van Tienoven, D., Lehr, J., Sweep, F.C. Breast Cancer Res. Treat. (2006) [Pubmed]
  4. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?. Span, P.N., Tjan-Heijnen, V.C., Heuvel, J.J., de Kok, J.B., Foekens, J.A., Sweep, F.C. Clin. Chem. (2006) [Pubmed]
  5. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. Span, P.N., Waanders, E., Manders, P., Heuvel, J.J., Foekens, J.A., Watson, M.A., Beex, L.V., Sweep, F.C. J. Clin. Oncol. (2004) [Pubmed]
  6. Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Span, P.N., Sweep, F.C., Wiegerinck, E.T., Tjan-Heijnen, V.C., Manders, P., Beex, L.V., de Kok, J.B. Clin. Chem. (2004) [Pubmed]
  7. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Span, P.N., Sweep, C.G., Manders, P., Beex, L.V., Leppert, D., Lindberg, R.L. Cancer (2003) [Pubmed]
  8. E1AF expression levels are not associated with prognosis in human breast cancer. Span, P.N., Manders, P., Heuvel, J.J., Beex, L.V., Sweep, C.G. Breast Cancer Res. Treat. (2003) [Pubmed]
  9. Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Span, P.N., Bussink, J., Manders, P., Beex, L.V., Sweep, C.G. Br. J. Cancer (2003) [Pubmed]
  10. Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. Span, P.N., Tjan-Heijnen, V.C., Manders, P., Beex, L.V., Sweep, C.G. Oncogene (2003) [Pubmed]
WikiGenes - Universities